Flagship Pioneering’s Denali Therapeutics DNLI Stock Holding History

Flagship Pioneering’s Portfolio DNLI Stock Details DNLI Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell
2024 Q1	$28M	Sell
2023 Q4	$49.8M	Sell
2023 Q3	$54M	Hold
2023 Q2	$77.3M	Hold
2023 Q1	$60.4M	Hold
2022 Q4	$72.9M	Hold
2022 Q3	$80.4M	Hold
2022 Q2	$77.1M	Hold
2022 Q1	$84.3M	Hold
2021 Q4	$117M	Sell
2021 Q3	$138M	Hold
2021 Q2	$214M	Hold
2021 Q1	$156M	Hold
2020 Q4	$229M	Sell
2020 Q3	$214M	Sell
2020 Q2	$193M	Hold
2020 Q1	$140M	Hold
2019 Q4	$139M	Sell
2019 Q3	$123M	Hold
2019 Q2	$166M	Hold
2019 Q1	$186M	Sell
2018 Q4	$184M	Hold
2018 Q3	$194M	Hold
2018 Q2	$136M	Hold
2018 Q1	$176M	Hold
2017 Q4	$139M	Buy